HEXPOL Valuation
Is HPOL B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HPOL B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HPOL B (SEK118) is trading below our estimate of fair value (SEK188.68)
Significantly Below Fair Value: HPOL B is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HPOL B?
Other financial metrics that can be useful for relative valuation.
| What is HPOL B's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | SEK 40.68b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2x |
| Enterprise Value/EBITDA | 10.3x |
| PEG Ratio | 3.1x |
Price to Earnings Ratio vs Peers
How does HPOL B's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 50.8x | ||
SSAB A SSAB | 4.9x | -10.9% | SEK 57.3b |
ITECH I-Tech | 23.7x | 30.3% | SEK 493.0m |
BILL Billerud | 153.1x | 39.4% | SEK 24.5b |
HOLM B Holmen | 21.3x | 7.4% | SEK 66.2b |
HPOL B HEXPOL | 16.2x | 5.2% | SEK 41.3b |
Price-To-Earnings vs Peers: HPOL B is good value based on its Price-To-Earnings Ratio (16.2x) compared to the peer average (50.8x).
Price to Earnings Ratio vs Industry
How does HPOL B's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings vs Industry: HPOL B is good value based on its Price-To-Earnings Ratio (16.2x) compared to the European Chemicals industry average (18.9x).
Price to Earnings Ratio vs Fair Ratio
What is HPOL B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.2x |
| Fair PE Ratio | 14.7x |
Price-To-Earnings vs Fair Ratio: HPOL B is expensive based on its Price-To-Earnings Ratio (16.2x) compared to the estimated Fair Price-To-Earnings Ratio (14.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | SEK 118.10 | SEK 139.67 +18.3% | 4.9% | SEK 147.00 | SEK 129.00 | n/a | 6 |
| Jun ’25 | SEK 128.20 | SEK 140.17 +9.3% | 5.8% | SEK 150.00 | SEK 129.00 | n/a | 6 |
| May ’25 | SEK 126.00 | SEK 136.67 +8.5% | 10.5% | SEK 150.00 | SEK 108.00 | n/a | 6 |
| Apr ’25 | SEK 130.60 | SEK 132.17 +1.2% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Mar ’25 | SEK 121.90 | SEK 132.17 +8.4% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Feb ’25 | SEK 120.70 | SEK 132.17 +9.5% | 9.7% | SEK 147.00 | SEK 108.00 | n/a | 6 |
| Jan ’25 | SEK 122.00 | SEK 122.00 0% | 6.6% | SEK 130.00 | SEK 108.00 | n/a | 5 |
| Dec ’24 | SEK 109.20 | SEK 120.60 +10.4% | 6.7% | SEK 130.00 | SEK 106.00 | n/a | 5 |
| Nov ’24 | SEK 99.55 | SEK 120.60 +21.1% | 6.7% | SEK 130.00 | SEK 106.00 | n/a | 5 |
| Oct ’24 | SEK 97.15 | SEK 122.80 +26.4% | 7.8% | SEK 135.00 | SEK 107.00 | n/a | 5 |
| Sep ’24 | SEK 106.90 | SEK 122.80 +14.9% | 7.8% | SEK 135.00 | SEK 107.00 | n/a | 5 |
| Aug ’24 | SEK 113.90 | SEK 122.80 +7.8% | 7.8% | SEK 135.00 | SEK 107.00 | n/a | 5 |
| Jul ’24 | SEK 114.30 | SEK 126.20 +10.4% | 8.7% | SEK 143.00 | SEK 110.00 | SEK 119.80 | 5 |
| Jun ’24 | SEK 111.20 | SEK 126.20 +13.5% | 8.7% | SEK 143.00 | SEK 110.00 | SEK 128.20 | 5 |
| May ’24 | SEK 120.70 | SEK 124.00 +2.7% | 9.3% | SEK 143.00 | SEK 110.00 | SEK 126.00 | 5 |
| Apr ’24 | SEK 128.50 | SEK 123.40 -4.0% | 8.5% | SEK 140.00 | SEK 110.00 | SEK 130.60 | 5 |
| Mar ’24 | SEK 117.40 | SEK 116.75 -0.6% | 3.5% | SEK 120.00 | SEK 110.00 | SEK 121.90 | 4 |
| Feb ’24 | SEK 114.90 | SEK 116.75 +1.6% | 3.5% | SEK 120.00 | SEK 110.00 | SEK 120.70 | 4 |
| Jan ’24 | SEK 111.10 | SEK 124.25 +11.8% | 9.7% | SEK 142.00 | SEK 110.00 | SEK 122.00 | 4 |
| Dec ’23 | SEK 114.70 | SEK 122.25 +6.6% | 9.8% | SEK 142.00 | SEK 110.00 | SEK 109.20 | 4 |
| Nov ’23 | SEK 109.00 | SEK 121.75 +11.7% | 10.3% | SEK 142.00 | SEK 108.00 | SEK 99.55 | 4 |
| Oct ’23 | SEK 91.90 | SEK 120.00 +30.6% | 11.2% | SEK 142.00 | SEK 108.00 | SEK 97.15 | 4 |
| Sep ’23 | SEK 93.05 | SEK 120.50 +29.5% | 10.9% | SEK 142.00 | SEK 108.00 | SEK 106.90 | 4 |
| Aug ’23 | SEK 103.30 | SEK 121.25 +17.4% | 10.3% | SEK 142.00 | SEK 111.00 | SEK 113.90 | 4 |
| Jul ’23 | SEK 87.15 | SEK 120.25 +38.0% | 10.5% | SEK 142.00 | SEK 111.00 | SEK 114.30 | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.